CompoAtlas

桂格完膳營養素腫瘤配方

桂格完膳營養素腫瘤配方 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
0980406945
Chinese name
桂格完膳營養素腫瘤配方
English name
QUAKER COMPLETE NUTRITION FOOD CACHEXIA FORMULA
Type
Special medical nutrition product
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
佳格食品股份有限公司
Form
液劑
Origin
台灣
Registration date
2009-12-21
Published validity end
2027-12-31

This product is special medical nutrition. Food supplement rules do not determine its compliance as a food for special medical purposes.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
MALTODEXTRINMALTODEXTRINMaltodextrine
CORN SYRUPCORN SYRUPNot identified
CALCIUM CASEINATECALCIUM CASEINATENot identified
SUCROSESUCROSENot identified
CANOLA OILCANOLA OILNot identified
SUNFLOWER SEED OILSUNFLOWER SEED OILNot identified
FIBERSOLFIBERSOLNot identified
GLUTAMINE PEPTIDEGLUTAMINE PEPTIDENot identified
MCTMCTTriglycérides à chaine moyenne
SOYBEAN OILSOYBEAN OILNot identified
WHEY PROTEIN CONCENTRATEWHEY PROTEIN CONCENTRATENot identified
VITAMIN PREMIXVITAMIN PREMIXNot identified
POTASSIUM CITRATEPOTASSIUM CITRATEPotassium
EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED)EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED)Not identified
FISH OIL POWDERFISH OIL POWDERNot identified
FLAVORFLAVORNot identified
SODIUM CHLORIDESODIUM CHLORIDENot identified
ARGININEARGININEArginine
TRIMAGNESIUM PHOSPHATETRIMAGNESIUM PHOSPHATEMagnésium
MINERAL PREMIXMINERAL PREMIXNot identified
SODIUM CITRATESODIUM CITRATENot identified
MAGNESIUM CARBONATEMAGNESIUM CARBONATEMagnésium
SOY PROTEIN ISOLATESOY PROTEIN ISOLATENot identified
INULININULINInuline
L-CARNITINEL-CARNITINEL-carnitine
NUCLEOTIDE PREMIXNUCLEOTIDE PREMIXNot identified
CARRAGEENANCARRAGEENANNot identified
DEIONIZED WATERDEIONIZED WATERNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
桂格完膳營養素腫瘤配方
Product form
液劑
Packaging
250.00000毫升;1500.00000毫升
Active ingredients
MALTODEXTRIN;CORN SYRUP;CALCIUM CASEINATE;SUCROSE;CANOLA OIL;SUNFLOWER SEED OIL;FIBERSOL;GLUTAMINE PEPTIDE;MCT;SOYBEAN OIL;WHEY PROTEIN CONCENTRATE;VITAMIN PREMIX;POTASSIUM CITRATE;EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED);FISH OIL POWDER;FLAVOR;SODIUM CHLORIDE;ARGININE;TRIMAGNESIUM PHOSPHATE;MINERAL PREMIX;SODIUM CITRATE;MAGNESIUM CARBONATE;SOY PROTEIN ISOLATE;INULIN;L-CARNITINE;NUCLEOTIDE PREMIX;CARRAGEENAN;DEIONIZED WATER
Valid until
2027/12/31
Registration number
0980406945
Origin
台灣
Licence holder
佳格食品股份有限公司
Registration date
2009/12/21
Published reference
DHD09804069459
Published English name
QUAKER COMPLETE NUTRITION FOOD CACHEXIA FORMULA

Official source

View the official register, number 0980406945

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ARGININE
    Read the warning, when it applies and the studies cited

    L-ARGININE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are pregnant or breastfeeding.

    Condition of application: Improvement in exercise capacity in individuals with stable CVD.

    Ask a health care practitioner/health care provider/health care professional/doctor/ physician if your symptoms worsen.

    Applies to products providing more than 0.42 g of L-Arginine, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you have a cardiovascular disease and are attempting an increase in physical activity (Doutreleau et al. 2010; Doutreleau et al. 2006; Schulman et al. 2006; Goldman and Ausiello 2004; Nagaya et al. 2001; Bednarz et al. 2000; Ceremużyński et al. 1997; Rector et al. 1996).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners (Huynh et al. 2002; Parker et al. 2002; Siani et al. 2000; Adams et al. 1995).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing more than 9 g of L-Arginine, per day.

    Do not use if you have had a heart attack/myocardial infarction (Sun et al. 2009; Schulman et al. 2006; Bednarz et al. 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Applies to products providing more than 9 g of L-Arginine, per day.

    When using this product you may experience gastrointestinal discomfort/disturbances (Grimble 2007; Evans et al. 2004; IOM 2005; Clarkson et al. 1996).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

  • L-CARNITINE
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line